Skip to main content
Top
Published in: International Cancer Conference Journal 1/2017

01-01-2017 | Case report

Hepatic angiosarcoma mimicking hepatic epithelioid hemangioendothelioma: report of a case

Authors: Hiroaki Shiba, Taro Sakamoto, Tomonori Iida, Kenei Furukawa, Koichiro Haruki, Katsuhiko Yanaga

Published in: International Cancer Conference Journal | Issue 1/2017

Login to get access

Abstract

A 78-year-old male was admitted to our hospital for treatment of multiple hepatic tumors, which were suspected as hepatic epithelioid hemangioendothelioma (HEHE) by percutaneous tumor needle biopsy. With a diagnosis of HEHE, the patient underwent hepatic resection. In pathological findings, the tumor was composed of numerous endothelial cells without epithelioid cells, and was diagnosed as hepatic angiosarcoma (HAS). The patient received percutaneous radiofrequency ablation for recurrent HAS at 5 and 25 months postoperatively, and remains well with recurrence as of 28 months after the primary hepatic resection. In spite of improvement in radiological imaging, preoperative differential diagnosis between HAS and other malignant vascular tumors of the liver is still difficult. We herein report a case of HAS mimicking HEHE, treated successfully.
Literature
1.
go back to reference Molina E, Hernandez A (2003) Clinical manifestations of primary hepatic angiosarcoma. Dig Dis Sci 48(4):677–682CrossRefPubMed Molina E, Hernandez A (2003) Clinical manifestations of primary hepatic angiosarcoma. Dig Dis Sci 48(4):677–682CrossRefPubMed
2.
go back to reference Yu RS, Chen Y, Jiang B, Wang LH, Xu XF (2008) Primary hepatic sarcomas: CT findings. Eur Radiol 18:2196–2205CrossRefPubMed Yu RS, Chen Y, Jiang B, Wang LH, Xu XF (2008) Primary hepatic sarcomas: CT findings. Eur Radiol 18:2196–2205CrossRefPubMed
3.
go back to reference Weitz J, Klimstra DS, Cymes K, Jarnagin WR, D’Angelica M, La Quaglia MP, Fong Y, Brennan MF, Blumgart LH, Dematteo RP (2007) Management of primary liver sarcomas. Cancer 109(7):1391–1396CrossRefPubMed Weitz J, Klimstra DS, Cymes K, Jarnagin WR, D’Angelica M, La Quaglia MP, Fong Y, Brennan MF, Blumgart LH, Dematteo RP (2007) Management of primary liver sarcomas. Cancer 109(7):1391–1396CrossRefPubMed
4.
go back to reference Groeschl RT, Miura JT, Oshima K, Gamblin TC, Turaga KK (2014) Does histology predict outcome for malignant vascular tumors of the liver? J Surg Oncol 109(5):483–486CrossRefPubMed Groeschl RT, Miura JT, Oshima K, Gamblin TC, Turaga KK (2014) Does histology predict outcome for malignant vascular tumors of the liver? J Surg Oncol 109(5):483–486CrossRefPubMed
5.
go back to reference Louagie YA, Gianello P, Kestens PJ, Bonbled F, Haot JG (1984) Vinylchloride induced hepatic angiosarcoma. Br J Surg. 71(4):322–323CrossRefPubMed Louagie YA, Gianello P, Kestens PJ, Bonbled F, Haot JG (1984) Vinylchloride induced hepatic angiosarcoma. Br J Surg. 71(4):322–323CrossRefPubMed
6.
go back to reference Timaran CH, Grandas OH, Bell JL (2000) Hepatic angiosarcoma: long-term survival after complete surgical removal. Am Surg. 66(12):1153–1157PubMed Timaran CH, Grandas OH, Bell JL (2000) Hepatic angiosarcoma: long-term survival after complete surgical removal. Am Surg. 66(12):1153–1157PubMed
7.
go back to reference Ozden I, Bilge O, Erkan M, Cevikbaş U, Acarli K (2003) Five years and 4 months of recurrence-free survival in hepatic angiosarcoma. J Hepatob Pancreat Surg 10(3):250–252CrossRef Ozden I, Bilge O, Erkan M, Cevikbaş U, Acarli K (2003) Five years and 4 months of recurrence-free survival in hepatic angiosarcoma. J Hepatob Pancreat Surg 10(3):250–252CrossRef
8.
go back to reference Duan XF, Li Q (2012) Primary hepatic angiosarcoma: a retrospective analysis of 6 cases. J Dig Dis 13(7):381–385CrossRefPubMed Duan XF, Li Q (2012) Primary hepatic angiosarcoma: a retrospective analysis of 6 cases. J Dig Dis 13(7):381–385CrossRefPubMed
9.
go back to reference Huang NC, Kuo YC, Chiang JC, Hung SY, Wang HM, Hung YM, Chang YT, Wann SR, Chang HT, Wang JS, Ho SY, Guo HR (2015) Hepatic angiosarcoma may have fair survival nowadays. Med (Baltimore) 94(19):e816CrossRef Huang NC, Kuo YC, Chiang JC, Hung SY, Wang HM, Hung YM, Chang YT, Wann SR, Chang HT, Wang JS, Ho SY, Guo HR (2015) Hepatic angiosarcoma may have fair survival nowadays. Med (Baltimore) 94(19):e816CrossRef
10.
11.
go back to reference Lee SW, Song CY, Gi YH, Kang SB, Kim YS, Nam SW, Lee DS, Kim JO (2008) Hepatic angiosarcoma manifested as recurrent hemoperitoneum. World J Gastroenterol 14(18):2935–2938CrossRefPubMedPubMedCentral Lee SW, Song CY, Gi YH, Kang SB, Kim YS, Nam SW, Lee DS, Kim JO (2008) Hepatic angiosarcoma manifested as recurrent hemoperitoneum. World J Gastroenterol 14(18):2935–2938CrossRefPubMedPubMedCentral
Metadata
Title
Hepatic angiosarcoma mimicking hepatic epithelioid hemangioendothelioma: report of a case
Authors
Hiroaki Shiba
Taro Sakamoto
Tomonori Iida
Kenei Furukawa
Koichiro Haruki
Katsuhiko Yanaga
Publication date
01-01-2017
Publisher
Springer Japan
Published in
International Cancer Conference Journal / Issue 1/2017
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-016-0268-4

Other articles of this Issue 1/2017

International Cancer Conference Journal 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine